Total Neoadjuvant Chemoradiation Combined with Neoadjuvant PD-1 Blockade for Patients with Pmmr, High-Risk, and Locally Advanced Middle to Low Rectal Cancer.
JOURNAL OF CLINICAL ONCOLOGY（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined